A randomized study in oral immunotherapy for food allergy by Ministry of Health, Labour and Welfare in JAPA
Not Applicable
- Conditions
- food allergy
- Registration Number
- JPRN-UMIN000003943
- Lead Sponsor
- Mie National Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) patients who have been treated with rush oral immunotherapy. 2) patients with poorly controlled asthma or atopic dermatitis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method A comparison of the dose response to double-blind, placebo-controlled food challenge (DBPCFC) before and after therapy between rush OIT group and elimination group. We will define the thresholds for clinically significant reactions in DBPCFC.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms drive oral immunotherapy (OIT) efficacy in JPRN-UMIN000003943 food allergy trial by Mie National Hospital?
How does OIT compare to conventional allergen avoidance strategies in managing IgE-mediated food allergies in Japanese populations?
Which biomarkers correlate with successful desensitization in JPRN-UMIN000003943 oral immunotherapy for food allergies?
What adverse events are reported in OIT protocols for food allergies, and how are they mitigated in Japanese clinical settings?
Are there combination therapies or alternative OIT approaches being evaluated for food allergies in Japan alongside JPRN-UMIN000003943?